Background The evidence on associations between ultra-processed foods (UPF) and lung cancer risk is limited and inconsistent.

Flow Cytometry's growth accelerates as immuno-oncology and liquid biopsy markets expand, driving cancer research investment. Explore advancements in single-cell genomics and biotech opportunities in ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Altria's dividend growth and high yield are appealing, supported by stable operating cash flows over the past decade. Check ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive surprises than negative ones.

In April 2025, Radiopharm dosed the first patient in the U.S. Phase 2b imaging study of 18F-RAD101. The multicenter, open-label, single arm Phase 2b clinical trial is evaluating the diagnostic ...

When the patient opted against surveillance CT scans and a follow-up PET scan, her physician ordered the CyPath® Lung test in March 2025. The test result of 0.56 – classified as “likely malignancy” – ...

Background Heart auscultation is a widely used and cost-effective clinical tool for detecting valvular heart disease (VHD), ...

Media Release The pivotal TACTI-004 Phase III trial in first line non-small cell lung cancer (1L NSCLC) continues to build momentum and is recruiting patients at a growing number of activated clinical ...

Roche Holding AG's H2 2025 earnings show solid growth in pharma revenues but highlight pipeline struggles and U.S. pricing pressures. Click for my RHHBY update.

Petro Matad Share Chat. Chat About MATD Shares - Stock Quote, Charts, Trade History, Share Chat, Financial Terms Glossary.